Synapse - Works

Results (5712)

A global phase 2 study of valemetostat tosylate (valemetostat) in patients with relapsed or refractory (R/R) peripheral T-cell lymphoma (PTCL), including R/R adult T-cell leukemia/lymphoma (ATL) - VALENTINE-PTCL01

Meeting Abstract

Foss, F. M.; Porcu, P.; Horwitz, S. M.; Izutsu, K.; Ishitsuka, K.; Kato, K.; Jin, J.; Du, Y.; Inoue, A.
Blood (2021)

Fulltext@MSK | Save

Racial disparities in access to alternative donor allografts persist in the era of "Donors for all"

Meeting Abstract

Fingrut, W.; Politikos, I.; Davis, E.; Chinapen, S.; Naputo, K.; Cho, C.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
Blood (2021)

Fulltext@MSK | Save

Machine learning of genomic factors in 1,961 patients with acute myeloid leukemia identifies patients with very good or very poor prognosis who do not benefit from allogeneic hematopoietic cell transplant in first remission

Meeting Abstract

Fleming, S.; Tsai, C. H.; Dohner, H.; Dohner, K.; Papaemmanuil, E.; Tien, H. F.; Reynolds, J.; Wei, A. H.; Hou, H. A.
Blood (2021)

Fulltext@MSK | Save

TP53 mutations and RNA binding protein MUSASHI 2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma

Meeting Abstract

Erazo, I. T.; Evans, C. M.; Zakheim, D.; Chu, K. L.; Barbash, O.; Refermat, A. Y.; Batlevi, C. L.; Younes, A.; Kharas, M. G.
Blood (2021)

Fulltext@MSK | Save

KIR-HLA interactions lack clinical utility in matched unrelated donor transplantation for AML: An analysis of the CIBMTR and DRST registries

Meeting Abstract

Fein, J. A.; Shouval, R.; Krieger, E.; Baldauf, H.; Fleischhauer, K.; Kroeger, N.; Horowitz, M. M.; Maiers, M.; Malmberg, K. J.; Miller, J. S.; more...
Blood (2021)

Fulltext@MSK | Save

Clinical outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg type treated in the rituximab era: Long-term follow-up of a single-center experience

Meeting Abstract

Falchi, L.; Qiu, A.; Ewalt, M. D.; Batlevi, C. L.; Caron, P. C.; Hamlin, P. A.; Hamilton, A.; Horwitz, S. M.; Joffe, E.; Khan, N.; more...
Blood (2021)

Fulltext@MSK | Save

DNMT3A mutations in the hematopoietic system promote colitis-associated colon cancer: A model of clonal hematopoiesis in solid tumors

Meeting Abstract

Feng, Y.; Newsome, R.; Robinson, T.; Bowman, R. L.; Zuniga, A.; Hall, K.; Bernsten, C.; Shabashvili, D.; Krajcik, K.; Gunaratne, C.; more...
Blood (2021)

Fulltext@MSK | Save

Effect of brentuximab vedotin addition to chemotherapy and prognostic factors in patients with relapsed/refractory hodgkin lymphoma: A large multi-trial analysis based on individual patient data

Meeting Abstract

Driessen, J.; de Wit, F.; Herrera, A. F.; Zinzani, P. L. L.; LaCasce, A. S.; Moskowitz, C. H.; Garcia-Sanz, R.; Cole, P. D.; Fuchs, M.; Mueller, H.; more...
Blood (2021)

Fulltext@MSK | Save

Deep phenotyping reveals expansion of T follicular regulatory cells and triple positive (CTLA4, TIGIT, PD1) exhausted effector memory T cells characterizing the immunosuppressive microenvironment in follicular lymphoma

Meeting Abstract

El Daker, S.; Freeman, D.; Baik, J.; Zhu, M.; Chattopadhyay, P.; Roshal, M.; Dogan, A.; Galera, P.
Blood (2021)

Fulltext@MSK | Save

Entospletinib (ENTO) and decitabine (DEC) combination therapy in older newly diagnosed (ND) acute myeloid leukemia (AML) patients with mutant TP53 or complex karyotype is associated with poor response and survival: A phase 2 sub-study of the Beat AML Master Trial

Meeting Abstract

Duong, V. H.; Ruppert, A. S.; Mims, A. S.; Borate, U.; Stein, E. M.; Baer, M. R.; Stock, W.; Kovacsovics, T.; Blum, W. G.; Arellano, M. L.; more...
Blood (2021)

Fulltext@MSK | Save